Posts

ISIS SMN-Rx Enters A New Study

Ampyra Might Improve Walking Ability in Spinal Muscular Atrophy

How ISIS SMN-Rx Was Developed

Study Confirms Link Between SMA and ALS

Repligen RG3039 Now in Phase 1b Trial